Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.77524
Nojoud Noureldayim Elsayid, Elwaleed Idrees Aydaross Adam, Samah Mohamed Yousif Mahmoud, Hoyam Saadeldeen, Muhammad Nauman, Tayseir Ahmed Ali Ahmed, Belgees Altigani Hamza Yousif, Allaa Ibrahim Awad Taha
To enhance patient outcomes in pediatric cancer, a better understanding of the medical and biological risk variables is required. With the growing amount of data accessible to research in pediatric cancer, machine learning (ML) is a form of algorithmic inference from sophisticated statistical techniques. In addition to highlighting developments and prospects in the field, the objective of this systematic study was to methodically describe the state of ML in pediatric oncology. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to search for relevant studies on four distinct databases (Scopus, Web of Science, PubMed, and Cochrane Library). A total of 1536 relevant studies were retrieved to the EndNote library (Clarivate, Philadelphia, USA) where duplicates were removed and the rest of the studies were assessed for eligibility based on titles, abstracts, and the availability of full-text articles. After assessing the studies for eligibility, we found 42 studies eligible for inclusion in this systematic review. We found nine studies on liquid tumors, 13 on solid tumors, and 20 on central nervous system (CNS) tumors. ML goals included classification, treatment response prediction, and dose optimization. Neural networks, k-nearest neighbors, random forests, support vector machines, and naive Bayes were among the techniques employed. The identified studies' strengths included treatment response prediction and automated analysis that matched or outperformed physician comparators. Significant variation in clinical applicability, criteria for reporting, limited sample numbers, and the absence of external validation cohorts were among the common issues. We found places where ML can improve clinical care in manners that would not be possible otherwise. Even though ML has great promise for enhancing pediatric cancer diagnosis, decision-making, and monitoring, the discipline is still in its infancy, and standards and recommendations will support future research to guarantee robust methodologic design and maximize therapeutic applicability.
为了提高儿童癌症患者的预后,需要更好地了解医学和生物学风险变量。随着儿科癌症研究可获得的数据越来越多,机器学习(ML)是一种从复杂的统计技术中进行算法推断的形式。除了强调该领域的发展和前景外,本系统研究的目的是系统地描述小儿肿瘤学中ML的状态。我们遵循系统评价和荟萃分析首选报告项目(PRISMA)指南,在四个不同的数据库(Scopus、Web of Science、PubMed和Cochrane Library)中搜索相关研究。共有1536项相关研究被检索到EndNote文库(Clarivate, Philadelphia, USA),其中删除了重复的研究,并根据标题、摘要和全文文章的可用性评估了其余研究的资格。在评估研究的合格性后,我们发现有42项研究符合纳入本系统评价的条件。我们发现9项关于液体肿瘤的研究,13项关于实体肿瘤的研究,20项关于中枢神经系统肿瘤的研究。ML目标包括分类、治疗反应预测和剂量优化。神经网络、k近邻、随机森林、支持向量机和朴素贝叶斯都是采用的技术。确定的研究的优势包括治疗反应预测和自动分析,与医生比较相匹配或优于医生比较。临床适用性的显著差异、报告标准、有限的样本数和缺乏外部验证队列是常见的问题。我们发现机器学习可以以其他方式改善临床护理的地方是不可能的。尽管ML在提高儿童癌症诊断、决策和监测方面有很大的前景,但该学科仍处于起步阶段,标准和建议将支持未来的研究,以保证稳健的方法设计和最大化的治疗适用性。
{"title":"The Role of Machine Learning Approaches in Pediatric Oncology: A Systematic Review.","authors":"Nojoud Noureldayim Elsayid, Elwaleed Idrees Aydaross Adam, Samah Mohamed Yousif Mahmoud, Hoyam Saadeldeen, Muhammad Nauman, Tayseir Ahmed Ali Ahmed, Belgees Altigani Hamza Yousif, Allaa Ibrahim Awad Taha","doi":"10.7759/cureus.77524","DOIUrl":"https://doi.org/10.7759/cureus.77524","url":null,"abstract":"<p><p>To enhance patient outcomes in pediatric cancer, a better understanding of the medical and biological risk variables is required. With the growing amount of data accessible to research in pediatric cancer, machine learning (ML) is a form of algorithmic inference from sophisticated statistical techniques. In addition to highlighting developments and prospects in the field, the objective of this systematic study was to methodically describe the state of ML in pediatric oncology. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to search for relevant studies on four distinct databases (Scopus, Web of Science, PubMed, and Cochrane Library). A total of 1536 relevant studies were retrieved to the EndNote library (Clarivate, Philadelphia, USA) where duplicates were removed and the rest of the studies were assessed for eligibility based on titles, abstracts, and the availability of full-text articles. After assessing the studies for eligibility, we found 42 studies eligible for inclusion in this systematic review. We found nine studies on liquid tumors, 13 on solid tumors, and 20 on central nervous system (CNS) tumors. ML goals included classification, treatment response prediction, and dose optimization. Neural networks, k-nearest neighbors, random forests, support vector machines, and naive Bayes were among the techniques employed. The identified studies' strengths included treatment response prediction and automated analysis that matched or outperformed physician comparators. Significant variation in clinical applicability, criteria for reporting, limited sample numbers, and the absence of external validation cohorts were among the common issues. We found places where ML can improve clinical care in manners that would not be possible otherwise. Even though ML has great promise for enhancing pediatric cancer diagnosis, decision-making, and monitoring, the discipline is still in its infancy, and standards and recommendations will support future research to guarantee robust methodologic design and maximize therapeutic applicability.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77524"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.77521
Zachary K Woodward, Goutham Sivasuthan, Ratna Aseervatham, Priscilla Martin
Background Sarcopenia is the progressive and generalized loss of skeletal muscle and its associated function. Whilst it is typically associated with advanced age, it is also prevalent in patients with chronic diseases including cancer. Patients with esophageal cancer are at high risk of developing malnutrition and sarcopenia due to impaired oral intake, the effects of neoadjuvant treatment, and cancer-related cachexia. Sarcopenia has been associated with worse postoperative outcomes. The aim of this study was to investigate the impacts sarcopenia had on the short- and long-term outcomes of patients undergoing esophagectomy in a regional Australian context. Methods A single-center retrospective analysis was performed for 48 patients who underwent esophagectomy, most of which were for esophageal cancer. All eligible patients received neoadjuvant treatment prior to surgery. Patients were classified as sarcopenic based on their calculated skeletal muscle index (SMI) on a preoperative computed tomography scan. SMI criteria for sarcopenia were <52.4 cm2/m2 for males and <38.5 cm2/m2 for females. Outcomes measured included overall and disease-free survival, postoperative complications, and length of hospital stay. Results Of the 44 patients who met inclusion criteria and underwent esophagectomy, 27 were sarcopenic based on preoperative computed tomography skeletal muscle measurements at L3. The average overall survival for the sarcopenic group was 20.1 months (95% CI 13.3-26.9) with a one-, two-, and three-year overall survival rate of 59.3%, 29.6%, and 22.2%, respectively. The non-sarcopenic group had an average overall survival rate of 28.8 months (95% CI 19.6-38.1) with a one-, two-, and three-year overall survival rate of 82.4%, 41.2%, and 29.4%, respectively. The average disease-free survival for the sarcopenic group was 14.1 months (95% CI 8.4-19.8) with a one-, two-, and three-year disease-free survival rate of 37.0%, 18.5%, and 11.1%, respectively. The average disease-free survival rate for the non-sarcopenic group was 27.2 months (95% CI 19.7-34.7) with a one-, two-, and three-year disease-free survival rate of 76.5%, 41.2%, and 29.4%, respectively. The sarcopenic group had an increased average length of hospital stay (23.9 days (CI 95% 16.5-31.3) vs. 14.6 days (95% CI 12.2-17.0)). A higher proportion of the sarcopenic patients had restricted dietary intake and required either pureed or enteral feeding (36% vs. 9%). No difference in postoperative complications was detected between the groups. Conclusions Patients with preoperative sarcopenia had a lower overall and disease-free survival and an increased length of hospital stay when compared with non-sarcopenic patients. Additionally, sarcopenic patients had a higher likelihood of requiring pureed or enteral feeds preoperatively.
骨骼肌减少症是骨骼肌及其相关功能的进行性和全身性丧失。虽然它通常与老年有关,但在患有慢性疾病(包括癌症)的患者中也很普遍。食管癌患者由于口服摄入受损、新辅助治疗的影响以及癌症相关的恶病质,发生营养不良和肌肉减少的风险很高。肌肉减少症与较差的术后预后有关。本研究的目的是调查澳大利亚地区食管癌患者骨骼肌减少症对其短期和长期预后的影响。方法对48例食管癌患者行食管切除术进行单中心回顾性分析。所有符合条件的患者在手术前接受新辅助治疗。根据术前计算机断层扫描计算的骨骼肌指数(SMI)将患者分类为肌肉减少症。肌肉减少症的SMI标准为男性2/m2,女性2/m2。测量的结果包括总生存率和无病生存率、术后并发症和住院时间。结果在44例符合纳入标准并行食管切除术的患者中,27例基于术前计算机断层扫描骨骼肌测量L3肌萎缩。肌肉减少组的平均总生存期为20.1个月(95% CI 13.3-26.9), 1年、2年和3年总生存率分别为59.3%、29.6%和22.2%。非肌肉减少组的平均总生存率为28.8个月(95% CI 19.6-38.1), 1年、2年和3年总生存率分别为82.4%、41.2%和29.4%。肌肉减少组的平均无病生存期为14.1个月(95% CI 8.4-19.8), 1年、2年和3年无病生存率分别为37.0%、18.5%和11.1%。非肌肉减少组的平均无病生存率为27.2个月(95% CI 19.7-34.7), 1年、2年和3年无病生存率分别为76.5%、41.2%和29.4%。肌肉减少组的平均住院时间增加(23.9天(95% CI 16.5-31.3) vs. 14.6天(95% CI 12.2-17.0))。较高比例的肌肉减少症患者限制饮食摄入,需要肠内或肠内喂养(36%对9%)。两组术后并发症发生率无差异。结论与非肌肉减少患者相比,术前肌肉减少患者的总生存期和无病生存期较低,住院时间较长。此外,肌肉减少症患者术前需要肠内或肠内喂养的可能性更高。
{"title":"Impact of Preoperative Sarcopenia on Survival and Postoperative Outcomes in Esophageal Cancer Patients Undergoing Esophagectomy: A Single-Center Retrospective Study.","authors":"Zachary K Woodward, Goutham Sivasuthan, Ratna Aseervatham, Priscilla Martin","doi":"10.7759/cureus.77521","DOIUrl":"https://doi.org/10.7759/cureus.77521","url":null,"abstract":"<p><p>Background Sarcopenia is the progressive and generalized loss of skeletal muscle and its associated function. Whilst it is typically associated with advanced age, it is also prevalent in patients with chronic diseases including cancer. Patients with esophageal cancer are at high risk of developing malnutrition and sarcopenia due to impaired oral intake, the effects of neoadjuvant treatment, and cancer-related cachexia. Sarcopenia has been associated with worse postoperative outcomes. The aim of this study was to investigate the impacts sarcopenia had on the short- and long-term outcomes of patients undergoing esophagectomy in a regional Australian context. Methods A single-center retrospective analysis was performed for 48 patients who underwent esophagectomy, most of which were for esophageal cancer. All eligible patients received neoadjuvant treatment prior to surgery. Patients were classified as sarcopenic based on their calculated skeletal muscle index (SMI) on a preoperative computed tomography scan. SMI criteria for sarcopenia were <52.4 cm<sup>2</sup>/m<sup>2</sup> for males and <38.5 cm<sup>2</sup>/m<sup>2</sup> for females. Outcomes measured included overall and disease-free survival, postoperative complications, and length of hospital stay. Results Of the 44 patients who met inclusion criteria and underwent esophagectomy, 27 were sarcopenic based on preoperative computed tomography skeletal muscle measurements at L3. The average overall survival for the sarcopenic group was 20.1 months (95% CI 13.3-26.9) with a one-, two-, and three-year overall survival rate of 59.3%, 29.6%, and 22.2%, respectively. The non-sarcopenic group had an average overall survival rate of 28.8 months (95% CI 19.6-38.1) with a one-, two-, and three-year overall survival rate of 82.4%, 41.2%, and 29.4%, respectively. The average disease-free survival for the sarcopenic group was 14.1 months (95% CI 8.4-19.8) with a one-, two-, and three-year disease-free survival rate of 37.0%, 18.5%, and 11.1%, respectively. The average disease-free survival rate for the non-sarcopenic group was 27.2 months (95% CI 19.7-34.7) with a one-, two-, and three-year disease-free survival rate of 76.5%, 41.2%, and 29.4%, respectively. The sarcopenic group had an increased average length of hospital stay (23.9 days (CI 95% 16.5-31.3) vs. 14.6 days (95% CI 12.2-17.0)). A higher proportion of the sarcopenic patients had restricted dietary intake and required either pureed or enteral feeding (36% vs. 9%). No difference in postoperative complications was detected between the groups. Conclusions Patients with preoperative sarcopenia had a lower overall and disease-free survival and an increased length of hospital stay when compared with non-sarcopenic patients. Additionally, sarcopenic patients had a higher likelihood of requiring pureed or enteral feeds preoperatively.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77521"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11740160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.77525
Glennie Ntsambi, Israël Maoneo, Renault Kambere, Larrey Kasereka Kamabu, Antoine Beltchika
Pediatric spinal tumors include a variety of developmental lesions and uncommon neoplasms that differ significantly from those seen in adults. These conditions are underreported in the sub-Saharan medical literature. We present the case of a 10-year-old girl brought by her family to the University Teaching Hospital of Kinshasa in the Democratic Republic of Congo with progressive lower limb functional impairment. On admission, the patient was alert, with normal vital signs, pink palpebral conjunctiva, anicteric sclerae, unremarkable cardiopulmonary and spinal examinations, and no spinal deformities. However, palpation revealed tenderness along the dorsal spinous processes from T1 to T10, and a sensory level corresponding to the T4 dermatome was noted. The patient was paraplegic and wheelchair-bound, with a lower limb American Spinal Injury Association (ASIA) motor score of 20/50. A CT scan of the thoracolumbar spine revealed no disc or vertebral abnormalities. An MRI demonstrated an extensive extradural, intracanal mass from T1 to T10 causing spinal cord compression. The mass exhibited signal characteristics suggestive of a fat-containing lesion. A posterior surgical approach was performed for tumor excision 20 days after admission. Histopathological analysis confirmed an inflammatory fibrolipomatous tumor. Postoperatively, the patient showed significant neurological improvement after three months of physiotherapy. This report highlights the diagnostic and therapeutic challenges associated with rare spinal lesions in children.
{"title":"Uncommon Extradural Spinal Fibrolipoma in a Child: A Case Report.","authors":"Glennie Ntsambi, Israël Maoneo, Renault Kambere, Larrey Kasereka Kamabu, Antoine Beltchika","doi":"10.7759/cureus.77525","DOIUrl":"https://doi.org/10.7759/cureus.77525","url":null,"abstract":"<p><p>Pediatric spinal tumors include a variety of developmental lesions and uncommon neoplasms that differ significantly from those seen in adults. These conditions are underreported in the sub-Saharan medical literature. We present the case of a 10-year-old girl brought by her family to the University Teaching Hospital of Kinshasa in the Democratic Republic of Congo with progressive lower limb functional impairment. On admission, the patient was alert, with normal vital signs, pink palpebral conjunctiva, anicteric sclerae, unremarkable cardiopulmonary and spinal examinations, and no spinal deformities. However, palpation revealed tenderness along the dorsal spinous processes from T1 to T10, and a sensory level corresponding to the T4 dermatome was noted. The patient was paraplegic and wheelchair-bound, with a lower limb American Spinal Injury Association (ASIA) motor score of 20/50. A CT scan of the thoracolumbar spine revealed no disc or vertebral abnormalities. An MRI demonstrated an extensive extradural, intracanal mass from T1 to T10 causing spinal cord compression. The mass exhibited signal characteristics suggestive of a fat-containing lesion. A posterior surgical approach was performed for tumor excision 20 days after admission. Histopathological analysis confirmed an inflammatory fibrolipomatous tumor. Postoperatively, the patient showed significant neurological improvement after three months of physiotherapy. This report highlights the diagnostic and therapeutic challenges associated with rare spinal lesions in children.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77525"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.r161
Mian Mufarih Shah, Imran Khan, Mehwash Iftikhar, Nazir Shah, Saeed Ur Rahman, Jahanzeb Khan
[This retracts the article DOI: 10.7759/cureus.72872.].
[此撤回文章DOI: 10.7759/cure .72872.]。
{"title":"Retraction: Doripenem, Ertapenem, and Meropenem Sensitivity in Salmonella Typhi: A Cross-Sectional Study From Pakistan.","authors":"Mian Mufarih Shah, Imran Khan, Mehwash Iftikhar, Nazir Shah, Saeed Ur Rahman, Jahanzeb Khan","doi":"10.7759/cureus.r161","DOIUrl":"https://doi.org/10.7759/cureus.r161","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.7759/cureus.72872.].</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"r161"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.77526
Correggio L Peagler, Philip Parel, Kennedy Musgrave, Sarah Dance, Roxana Martinez, Savyasachi C Thakkar, Sean A Tabaie
Introduction Total hip arthroplasty (THA) is rarely indicated in the skeletally immature population. In these instances, there is concern for implant survival compared to the traditional older population. There has been a steady rise in the use of THA in the pediatric population due to improvements in surgical techniques. While the outcomes in THA for skeletally immature patients have been described in the literature, there are no population studies looking at this procedure in a skeletally immature individual. Therefore, the purpose of this study was to compare 10-year implant survivability following primary THA in skeletally mature versus skeletally immature patients. Methods Patients who underwent primary THA were identified using a large national database (PearlDiver). THA patients were then divided into presumed skeletally immature male patients (0-16 years), presumed skeletally mature male patients (17-21 years), presumed skeletally immature females (0-14 years), and presumed skeletally mature females (15-21 years). Multivariable analysis was conducted using Cox proportional hazards modeling to determine differences in the risk of revision for periprosthetic joint infection (PJI), mechanical loosening, dislocation/instability, and periprosthetic fracture (PPF). Results In total, 352 male patients (244 skeletally mature and 108 skeletally immature) and 409 female patients (350 skeletally mature and 59 skeletally immature) were identified. Compared to skeletally immature females, skeletally mature females had no higher risk of 10-year revision for all-cause, PJI, mechanical loosening, dislocation/instability, or PPF (P > 0.05 for all). Compared to skeletally immature males, skeletally mature males had no higher risk of 10-year revision for all-cause, PJI, mechanical loosening, dislocation/instability, or PPF (P > 0.05 for all). Conclusion Although THA occurred more commonly in patients above the presumed age of skeletal maturity, the lack of significantly different surgical outcomes suggests that younger age and presumed skeletal immaturity may not put patients at any further risk of implant failure. While further research is needed to understand the impact of age and skeletal maturity on outcomes of THA, these results indicate that the initial age of a THA may not be a factor in optimizing outcomes, and suggests that orthopedic surgeons need not delay surgery based on age or skeletal maturity alone.
{"title":"Skeletal Maturity Might Not Be a Factor in Optimizing Outcomes in Total Hip Arthroplasty.","authors":"Correggio L Peagler, Philip Parel, Kennedy Musgrave, Sarah Dance, Roxana Martinez, Savyasachi C Thakkar, Sean A Tabaie","doi":"10.7759/cureus.77526","DOIUrl":"https://doi.org/10.7759/cureus.77526","url":null,"abstract":"<p><p>Introduction Total hip arthroplasty (THA) is rarely indicated in the skeletally immature population. In these instances, there is concern for implant survival compared to the traditional older population. There has been a steady rise in the use of THA in the pediatric population due to improvements in surgical techniques. While the outcomes in THA for skeletally immature patients have been described in the literature, there are no population studies looking at this procedure in a skeletally immature individual. Therefore, the purpose of this study was to compare 10-year implant survivability following primary THA in skeletally mature versus skeletally immature patients. Methods Patients who underwent primary THA were identified using a large national database (PearlDiver). THA patients were then divided into presumed skeletally immature male patients (0-16 years), presumed skeletally mature male patients (17-21 years), presumed skeletally immature females (0-14 years), and presumed skeletally mature females (15-21 years). Multivariable analysis was conducted using Cox proportional hazards modeling to determine differences in the risk of revision for periprosthetic joint infection (PJI), mechanical loosening, dislocation/instability, and periprosthetic fracture (PPF). Results In total, 352 male patients (244 skeletally mature and 108 skeletally immature) and 409 female patients (350 skeletally mature and 59 skeletally immature) were identified. Compared to skeletally immature females, skeletally mature females had no higher risk of 10-year revision for all-cause, PJI, mechanical loosening, dislocation/instability, or PPF (P > 0.05 for all). Compared to skeletally immature males, skeletally mature males had no higher risk of 10-year revision for all-cause, PJI, mechanical loosening, dislocation/instability, or PPF (P > 0.05 for all). Conclusion Although THA occurred more commonly in patients above the presumed age of skeletal maturity, the lack of significantly different surgical outcomes suggests that younger age and presumed skeletal immaturity may not put patients at any further risk of implant failure. While further research is needed to understand the impact of age and skeletal maturity on outcomes of THA, these results indicate that the initial age of a THA may not be a factor in optimizing outcomes, and suggests that orthopedic surgeons need not delay surgery based on age or skeletal maturity alone.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77526"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736506/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-16eCollection Date: 2025-01-01DOI: 10.7759/cureus.77567
Chinedu E Unadike, Ayden Ismail, Akshay Harikumar, Omer Ali, Abdul Khan
Meckel's diverticulum (MD) is the most common congenital abnormality of the gastrointestinal tract. It usually lies on the antimesenteric side of the ileum, about 60 cm from the ileocecal valve. Histologically, it is a true diverticulum comprising all four layers of the intestinal tract. Complications associated with MD include bleeding, bowel obstruction, intussusception, and inflammation (diverticulitis). A 12-year-old boy presented to the emergency department with a one-day history of right iliac fossa pain. He had rebound tenderness and localized peritonism. The inflammatory markers were raised. He was listed for an emergency laparoscopic appendicectomy. Intraoperatively, a large necrotic MD was identified, twisted on its pedicle. In addition, a fibrous band extended from the tip of the diverticulum to the posterior aspect of the anterior abdominal wall. A closed-loop, discoloured terminal ileal volvulus with proximal small bowel dilatation was noted. The band was released by sharp dissection, and the terminal ileum volvulus was freed with the return of normal colour and circulation. The gangrenous Meckel's diverticulum was excised at its pedicle by ECHELON FLEX™ ENDOPATH® staplers (Ethicon, Inc., a Johnson & Johnson company, Raritan, NJ). The postoperative recovery was uneventful. Early laparoscopic intervention prevented irreversible small bowel ischaemia that may have resulted in resection of the terminal ileum in a child.
梅克尔憩室(MD)是最常见的先天性胃肠道异常。它通常位于回肠的反肠侧,距回盲瓣约60厘米。组织学上,它是一个真正的憩室,包括肠道的所有四层。MD的并发症包括出血、肠梗阻、肠套叠和炎症(憩室炎)。一个12岁的男孩以一天的右髂窝疼痛史来到急诊科。他有反跳压痛和局部腹胀。炎症标志物升高。他被安排做紧急腹腔镜阑尾切除术。术中发现一个大的坏死MD,其蒂扭曲。此外,纤维带从憩室尖端延伸至前腹壁后部。闭环,变色末端回肠扭转近端小肠扩张被注意到。通过锋利的解剖释放束,随着颜色和循环恢复正常,回肠扭转末端得到释放。坏疽性梅克尔憩室经ECHELON FLEX™ENDOPATH®吻合器(Ethicon, Inc., Johnson & Johnson company, ritan, NJ)从其蒂处切除。术后恢复顺利。早期腹腔镜干预预防不可逆的小肠缺血,可能导致切除回肠末端的儿童。
{"title":"Ischaemic Meckel's Diverticulum, Mesodiverticular Band, and Small Bowel Volvulus With Closed Loop Obstruction: A Laparoscopic Approach and Literature Review.","authors":"Chinedu E Unadike, Ayden Ismail, Akshay Harikumar, Omer Ali, Abdul Khan","doi":"10.7759/cureus.77567","DOIUrl":"https://doi.org/10.7759/cureus.77567","url":null,"abstract":"<p><p>Meckel's diverticulum (MD) is the most common congenital abnormality of the gastrointestinal tract. It usually lies on the antimesenteric side of the ileum, about 60 cm from the ileocecal valve. Histologically, it is a true diverticulum comprising all four layers of the intestinal tract. Complications associated with MD include bleeding, bowel obstruction, intussusception, and inflammation (diverticulitis). A 12-year-old boy presented to the emergency department with a one-day history of right iliac fossa pain. He had rebound tenderness and localized peritonism. The inflammatory markers were raised. He was listed for an emergency laparoscopic appendicectomy. Intraoperatively, a large necrotic MD was identified, twisted on its pedicle. In addition, a fibrous band extended from the tip of the diverticulum to the posterior aspect of the anterior abdominal wall. A closed-loop, discoloured terminal ileal volvulus with proximal small bowel dilatation was noted. The band was released by sharp dissection, and the terminal ileum volvulus was freed with the return of normal colour and circulation. The gangrenous Meckel's diverticulum was excised at its pedicle by ECHELON FLEX™ ENDOPATH® staplers (Ethicon, Inc., a Johnson & Johnson company, Raritan, NJ). The postoperative recovery was uneventful. Early laparoscopic intervention prevented irreversible small bowel ischaemia that may have resulted in resection of the terminal ileum in a child.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77567"},"PeriodicalIF":1.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Persistent hypotony following Tanito microhook trabeculotomy (TMH) is rare but may occur due to the development of cyclodialysis clefts. We report a case of a Japanese man in his 40s who developed persistent hypotony and hypotony maculopathy after TMH in the left eye. Fourteen months after the surgery, the patient was referred to our institution due to prolonged hypotony that remained undiagnosed and untreated despite evaluations with gonioscopy and anterior segment optical coherence tomography (AS-OCT) at the referring clinic. At our institution, default AS-OCT scans and gonioscopy also failed to identify the cleft due to anterior iris rotation caused by ciliary body detachment. However, manual AS-OCT scans successfully revealed angle detachment and irido-trabecular contact at 203°. The patient underwent combined cataract surgery and direct internal cyclopexy to repair the cyclodialysis cleft. While the surgery successfully resolved hypotony, it resulted in elevated intraocular pressure, necessitating Ahmed glaucoma valve implantation. This case emphasizes the importance of detailed AS-OCT scanning in detecting subtle cyclodialysis clefts and highlights direct internal cyclopexy as an effective treatment option for prolonged hypotony after TMH.
{"title":"A Case of Long-Term Undiagnosed Cyclodialysis Cleft Following Tanito Microhook Trabeculotomy.","authors":"Hinako Ohtani, Akiko Harano, Sho Ichioka, Ayaka Shimada, Mizuki Iida, Kana Murakami, Chisako Ida, Masaki Tanito","doi":"10.7759/cureus.77516","DOIUrl":"https://doi.org/10.7759/cureus.77516","url":null,"abstract":"<p><p>Persistent hypotony following Tanito microhook trabeculotomy (TMH) is rare but may occur due to the development of cyclodialysis clefts. We report a case of a Japanese man in his 40s who developed persistent hypotony and hypotony maculopathy after TMH in the left eye. Fourteen months after the surgery, the patient was referred to our institution due to prolonged hypotony that remained undiagnosed and untreated despite evaluations with gonioscopy and anterior segment optical coherence tomography (AS-OCT) at the referring clinic. At our institution, default AS-OCT scans and gonioscopy also failed to identify the cleft due to anterior iris rotation caused by ciliary body detachment. However, manual AS-OCT scans successfully revealed angle detachment and irido-trabecular contact at 203°. The patient underwent combined cataract surgery and direct internal cyclopexy to repair the cyclodialysis cleft. While the surgery successfully resolved hypotony, it resulted in elevated intraocular pressure, necessitating Ahmed glaucoma valve implantation. This case emphasizes the importance of detailed AS-OCT scanning in detecting subtle cyclodialysis clefts and highlights direct internal cyclopexy as an effective treatment option for prolonged hypotony after TMH.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77516"},"PeriodicalIF":1.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-15eCollection Date: 2025-01-01DOI: 10.7759/cureus.77510
Huber Díaz, Ricardo A Millán Flores, Héctor A Ancona Pérez, Brenda V Ventura Trujeque
Myelolipoma of the adrenal gland is a rare, benign, non-functioning tumor characterized by the presence of adipose tissue and bone marrow elements. We present the case of a 48-year-old woman with intermittent left flank pain and an incidental finding of an adrenal tumor on computed tomography. The patient underwent laparoscopic tumor resection due to the large size of the tumor. The decision to perform surgery was based on the tumor size and the patient's symptoms. Laparoscopic adrenalectomy is a safe surgical technique with low complication rates and shorter hospital stays.
{"title":"Unilateral Giant Myelolipoma of the Adrenal Gland: A Case Report.","authors":"Huber Díaz, Ricardo A Millán Flores, Héctor A Ancona Pérez, Brenda V Ventura Trujeque","doi":"10.7759/cureus.77510","DOIUrl":"https://doi.org/10.7759/cureus.77510","url":null,"abstract":"<p><p>Myelolipoma of the adrenal gland is a rare, benign, non-functioning tumor characterized by the presence of adipose tissue and bone marrow elements. We present the case of a 48-year-old woman with intermittent left flank pain and an incidental finding of an adrenal tumor on computed tomography. The patient underwent laparoscopic tumor resection due to the large size of the tumor. The decision to perform surgery was based on the tumor size and the patient's symptoms. Laparoscopic adrenalectomy is a safe surgical technique with low complication rates and shorter hospital stays.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":"17 1","pages":"e77510"},"PeriodicalIF":1.0,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11737461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}